Home
Conditions
Carcinoma, Squamous Cell

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

417 public trials 87 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Active, not recruiting

Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

NCT05048459

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Active, not recruiting

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

NCT05574101

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +14 more
Locations: University of Colorado (Data Collection Only) Aurora, Colorado, United States

Moffitt Cancer Center (Data Collection Only) Tampa, Florida, United States

Memorial Sloan Kettering Cancer Center at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

View all 13 locations

View Trial Details

Active, not recruiting

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

NCT01512589

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

NCT01706939

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, not recruiting

Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

NCT03737734

Conditions: Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +30 more
Locations: Davidof Cancer Institution at the Rabin Medical Center Israel Petah Tikva, Israel

View Trial Details

Active, not recruiting

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

NCT03174275

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +31 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Active, not recruiting

1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

NCT04150900

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
Locations: University of Maryland Medical Center Baltimore, Maryland, United States

View Trial Details

Active, not recruiting

A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

NCT06041802

Conditions: Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
Locations: Nagoya University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan

Sapporo Medical University Hospital ( Site 0002) Sapporo, Hokkaido, Japan

Yokohama City University Hospital ( Site 0016) Yokohama, Kanagawa, Japan

Tohoku University Hospital ( Site 0019) Sendai, Miyagi, Japan

View all 18 locations

View Trial Details

Active, not recruiting

Artificial Intelligence Patient App for RDEB SCCs

NCT05843994

Conditions: Carcinoma, Carcinoma, Squamous Cell, Collagen Diseases, +17 more
Locations: Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Pembrolizumab Plus Olaparib in LA-HNSCC

NCT05366166

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations: Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

University of Louisville, Brown Cancer Center Louisville, Kentucky, United States

UNC Lineberger Chapel Hill, North Carolina, United States

Medical University of South Carolina (MUSC) Charleston, South Carolina, United States

View Trial Details

Carcinoma, Squamous Cell

Carcinoma, Squamous Cell trial results

Related conditions